PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email(s)
40643037,Effects of tris(2-chloroethyl)phosphate on hyperuricemia revealed by network toxicology and ,2025,Yongxiao Huang; Caina Jiang; Fangyao Li; Xianli Ma,"Guangxi Key Laboratory of Drug Discovery and Optimization, Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Druggability Evaluation, Guilin, China.; Guangxi Key Laboratory of Drug Discovery and Optimization, Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Druggability Evaluation, Guilin, China.; Guangxi Key Laboratory of Drug Discovery and Optimization, Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Druggability Evaluation, Guilin, China.; Guangxi Key Laboratory of Drug Discovery and Optimization, Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Druggability Evaluation, Guilin, China.",N/A; N/A; N/A; N/A
40626318,Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad-Neutralizing Antibody Response against SARS-CoV-2 Omicron Subvariants.,2025,Kai Ji; Xishan Lu; Bo Ying,"Suzhou Abogen Biosciences Co., Ltd. Suzhou Jiangsu China.; Suzhou Abogen Biosciences Co., Ltd. Suzhou Jiangsu China.; Suzhou Abogen Biosciences Co., Ltd. Suzhou Jiangsu China.",N/A; N/A; N/A
